May 15, 2026 07:53AM

May 15, 2026 03:35AM

May 14, 2026 04:01PM

Mar 24, 2026 05:46PM

Mar 24, 2026 01:02PM

Mar 24, 2026 09:35AM

Mar 24, 2026 07:36AM Aardvark Therapeutics (AARD) Reiterated at Overweight by Cantor Fitzgerald After Q4 Results

Mar 24, 2026 05:14AM

Mar 23, 2026 09:05PM

Mar 23, 2026 05:12PM

Mar 2, 2026 07:29AM

Mar 2, 2026 06:10AM

Mar 2, 2026 06:07AM

Mar 2, 2026 02:53AM Stifel Downgrades Aardvark Therapeutics Inc (AARD) to Hold

Mar 2, 2026 02:38AM

Mar 2, 2026 02:38AM

Mar 2, 2026 12:41AM

Feb 12, 2026 08:03AM

Jan 28, 2026 02:18AM

Jan 12, 2026 04:47AM

Dec 23, 2025 06:04AM Oppenheimer Starts Aardvark Therapeutics Inc (AARD) at Outperform

Dec 12, 2025 04:06AM

Dec 11, 2025 03:55PM

Dec 11, 2025 12:23PM

Dec 2, 2025 04:06PM

Nov 14, 2025 07:58AM

Nov 14, 2025 07:08AM

Nov 14, 2025 04:30AM Aardvark Therapeutics Inc (AARD) PT Lowered to $18 at RBC Capital

Nov 13, 2025 06:52PM

Nov 7, 2025 06:06AM

Sep 30, 2025 04:31PM

Sep 29, 2025 12:47AM

Sep 23, 2025 06:36AM

Aug 21, 2025 08:00AM

Aug 14, 2025 10:48AM Aardvark Therapeutics Inc (AARD) PT Lowered to $19 at RBC Capital

Aug 14, 2025 07:24AM

Aug 13, 2025 05:52PM

Aug 12, 2025 08:04AM

Jun 30, 2025 06:40AM

May 19, 2025 04:15PM

Apr 1, 2025 08:18AM

Apr 1, 2025 07:11AM Cantor Fitzgerald Reiterates Overweight Rating on Aardvark Therapeutics Inc (AARD)

Mar 27, 2025 05:18AM

Mar 26, 2025 09:45AM

Mar 10, 2025 06:23AM

Mar 10, 2025 05:16AM

Mar 10, 2025 01:57AM

Jan 23, 2025 05:01PM

416,807 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All